Search

… QBRI Insights: Battling COVID-19 with CRISPR 12 May 2020 Home Entity: Qatar Biomedical Research Institute CRISPR … Interspaced Short Palindromic Repeats’ and is one of the major breakthroughs in modern molecular biology. This week QBRI experts explain how this bacterial immune system can be used to treat and diagnose COVID-19 in humans. CRISPR … Alexandra E. Butler For references, please click  here .   Related News View all news QBRI Insights: Breast Cancer and the Importance of Awareness 17 Nov 2022 Read more HBKU’s QBRI Wraps Up Summer Research …

… QBRI Insights: COVID-19 Vaccine Development - A Race Against Time 19 May 2020 Home Entity: Qatar Biomedical Research … life’ as we have always known it has collapsed worldwide due to COVID-19, which is caused by SARS-CoV-2. This week QBRI experts discuss why a vaccine is the only hope for resuming normality and highlight recent progress in multipronged … Investigator) For references, please click  here .   Related News View all news QBRI Insights: Breast Cancer and the Importance of Awareness 17 Nov 2022 Read more HBKU’s QBRI Wraps Up Summer Research …

… QBRI Insights: COVID-19: Serological Tests and Neurological Complications 02 Jun 2020 Home Entity: Qatar Biomedical … rapid, scalable and inexpensive diagnostic tests to identify symptomatic and asymptomatic cases. In edition two of QBRI Insights, the institute’s experts explained the rationale behind serology-based tests.  But how are these tests … human lung cells by binding to the ACE2 receptor – which was covered in edition three (https://www.hbku.edu.qa/en/news/qbri-insights-biology) present on the cell surface, ACE2 is also present on endothelial cells - the layer of cells …

… QBRI Insights: SARS-CoV-2 Stability and Neutralization 10 Jun 2020 Home Entity: Qatar Biomedical Research Institute Most … virus. But is the virus airborne too? And once inside the human body, can the virus be neutralized? This week, QBRI experts discuss recent studies highlighting the surface and aerosol stability of SARS-CoV-2 and scientific advances … cell surface through the receptor binding domain (RBD) of the spike protein S1 subunit ( https://www.hbku.edu.qa/en/news/qbri-insights-biology ) (5, 6). Therefore, blocking the ‘virus-host attachment’ using specific neutralizing antibodies …

… QBRI Insights: COVID-19 Diagnostic Biomarkers and Anti-Viral Treatments 16 Jun 2020 Home Entity: Qatar Biomedical … our understanding of the disease, its progression, and opportunities for intervention to treat patients. This week, QBRI experts discuss various parameters that can reflect the COVID-19 patient status and highlight key results from early … gold standard for diagnosis remains the Polymerase Chain Reaction (PCR) molecular test https://www.hbku.edu.qa/en/news/qbri-insights-biology , and the limitations surrounding the clinical criteria could be overcome by the implementation of …

… QBRI Insights: Influence of Host and Viral Genome Variation on COVID-19 24 Jun 2020 Home Entity: Qatar Biomedical … and ‘G’. In comparison, the SARS-CoV-2 genome is much smaller, with only about 29,000 nucleotides. This week, QBRI experts discuss how variations in the human host and viral genome sequence may determine the risk and severity of … of novel variants. Section Contributors Mutation of SARS-CoV-2: Dr. Nishant N. Vaikath (Research Associate, QBRI) Genotyping as an Accessory COVID-19 Diagnostic Tool: Dr. Salam Salloum Asfar (Postdoctoral Researcher, QBRI) Arabic …

… QBRI Insights: COVID-19 in Pediatric Cases and Diabetic Patient Management 07 Jul 2020 Home Entity: Qatar Biomedical … have been intensively studying the etiology of this disease and discerning its risk is population sub-groups. This week, QBRI experts discuss what is known about COVID-19 in children and how the disease can be managed in high-risk diabetic … to reduce mortality risks. Section Contributors: COVID-19 in children: Dr. Vijay Gupta (Postdoctoral Researcher, QBRI) Patient management in COVID-19 with diabetes mellitus: Dr. Manjula Nandakumar (Senior Research Associate, QBRI) …

… QBRI Insights: Severe COVID-19 Immunopathology and Computed Tomography-Based Diagnosis 21 Jul 2020 Home Entity: Qatar … patients experience mild symptoms, about 20% of cases develop severe pneumonia and respiratory failure. This week, QBRI experts discuss the hyper-activation of the immune defense system and detection of pneumonia by Computed Tomography … from: Link Section Contributors: The immune landscape in severe COVID-19: Dr. Yoshie Kobayashi (Postdoctoral Researcher, QBRI) Computed tomography (CT) scanning- a complementary COVID-19 diagnostic method: Dr. Afif Ben Mahmoud (Senior …

… QBRI Insights: COVID-19 and Liver Disease 11 Aug 2020 Home Entity: Qatar Biomedical Research Institute One established … COVID-19 fact is that disease severity increases with age and in patients with underlying health conditions. This week, QBRI experts discuss the effect of SARS-CoV-2 infection on the liver and its impact on patients suffering from liver … infection with SARS‐CoV‐2 remain the best defense.  Section Contributors Dr. Olfa Khalifa (Postdoctoral Researcher, QBRI) and Neyla Al-Akl (Senior Research Associate, QBRI)   Illustration by: Dr. Olfa Khalifa and Neyla Al-Akl Arabic text …

… QBRI Insights: COVID-19 vaccine and treatment updates 26 Aug 2020 Home Entity: Qatar Biomedical Research Institute About … dollar global investment, the race for vaccine and treatment development has been unprecedented. This week, QBRI experts provide an update on the current vaccine trials and the repurposed drug dexamethasone for COVID-19 … developing countries. Section Contributors The COVID-19 vaccine race: Dr. Salam Saloum-Asfar (Postdoctoral Researcher, QBRI)  Dexamethasone in COVID-19 treatment: Dr. Abu Saleh Md Moin (Postdoctoral Researcher, QBRI) Illustration by:  Dr. …